Intramyocardial hemorrhage could be a major cause of reperfusion injury after MI and contribute to myocardial damage, a new study has found, giving new leads for therapeutic intervention.
Instead of taking the traditional approach of replacing what s missing, the idea of fitusiran is to short circuit the body s anticoagulation system by targeting antithrombin.
Measurement of the biomarker copeptin in the ambulance may allow medics to quickly rule out myocardial infarction in patients with chest pain, randomized results of the AROMI trial suggest.